PortfoliosLab logoPortfoliosLab logo
GIB vs. OPRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GIB vs. OPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CGI Inc (GIB) and OptimizeRx Corporation (OPRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GIB achieves a -27.08% return, which is significantly higher than OPRX's -47.72% return. Over the past 10 years, GIB has underperformed OPRX with an annualized return of 4.42%, while OPRX has yielded a comparatively higher 18.64% annualized return.


GIB

1D
0.25%
1M
0.21%
6M
-28.26%
YTD
-27.08%
1Y
-32.90%
3Y*
-13.48%
5Y*
-5.94%
10Y*
4.42%

OPRX

1D
2.07%
1M
21.40%
6M
-51.29%
YTD
-47.72%
1Y
-49.53%
3Y*
-24.61%
5Y*
-35.05%
10Y*
18.64%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GIB vs. OPRX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GIB
CGI Inc
-27.08%-15.19%2.07%24.47%-2.68%11.59%-5.26%36.80%12.63%13.12%
OPRX
OptimizeRx Corporation
-47.72%152.26%-66.04%-14.82%-72.95%99.33%203.41%-6.38%598.73%93.83%

Correlation

The correlation between GIB and OPRX is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Jul 13, 2007

0.11

The correlation between GIB and OPRX shifts across timeframes, from 0.11 (all time) to 0.29 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

GIB:

$14.57B

OPRX:

$120.28M

EPS

GIB:

CA$7.71

OPRX:

$0.36

PE Ratio

GIB:

12.31

OPRX:

17.87

PEG Ratio

GIB:

1.54

OPRX:

0.03

PS Ratio

GIB:

1.26

OPRX:

1.14

PB Ratio

GIB:

2.02

OPRX:

0.93

Total Revenue (TTM)

GIB:

CA$16.35B

OPRX:

$107.35M

Gross Profit (TTM)

GIB:

CA$3.35B

OPRX:

$70.86M

EBITDA (TTM)

GIB:

CA$2.98B

OPRX:

$16.55M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GIB vs. OPRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GIB
GIB Risk / Return Rank: 66
Overall Rank
GIB Sharpe Ratio Rank: 33
Sharpe Ratio Rank
GIB Sortino Ratio Rank: 77
Sortino Ratio Rank
GIB Omega Ratio Rank: 55
Omega Ratio Rank
GIB Calmar Ratio Rank: 99
Calmar Ratio Rank
GIB Martin Ratio Rank: 55
Martin Ratio Rank

OPRX
OPRX Risk / Return Rank: 1919
Overall Rank
OPRX Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
OPRX Sortino Ratio Rank: 1717
Sortino Ratio Rank
OPRX Omega Ratio Rank: 1818
Omega Ratio Rank
OPRX Calmar Ratio Rank: 2020
Calmar Ratio Rank
OPRX Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GIB vs. OPRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CGI Inc (GIB) and OptimizeRx Corporation (OPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GIBOPRXDifference
Sharpe ratioReturn per unit of total volatility

-0.51

Sortino ratioReturn per unit of downside risk

-0.75

Omega ratioGain probability vs. loss probability

0.79

0.91

-0.12

Calmar ratioReturn relative to maximum drawdown

-0.86

-0.66

-0.20

Martin ratioReturn relative to average drawdown

-1.54

-1.04

-0.51

GIB vs. OPRX - Sharpe Ratio Comparison

The current GIB Sharpe Ratio is -1.17, which is lower than the OPRX Sharpe Ratio of -0.66. The chart below compares the historical Sharpe Ratios of GIB and OPRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GIB vs. OPRX - Drawdown Comparison

The maximum GIB drawdown since its inception was -86.78%, smaller than the maximum OPRX drawdown of -99.32%. Use the drawdown chart below to compare losses from any high point for GIB and OPRX.


Loading charts...

Drawdown Indicators


GIBOPRXDifference

Max Drawdown

Largest peak-to-trough decline

-86.78%

-99.32%

+12.54%

Max Drawdown (1Y)

Largest decline over 1 year

-39.72%

-79.06%

+39.34%

Max Drawdown (3Y)

Largest decline over 3 years

-49.54%

-79.06%

+29.52%

Max Drawdown (5Y)

Largest decline over 5 years

-49.54%

-96.10%

+46.56%

Max Drawdown (10Y)

Largest decline over 10 years

-49.54%

-96.10%

+46.56%

Current Drawdown

Current decline from peak

-44.78%

-93.46%

+48.68%

Average Drawdown

Average peak-to-trough decline

-32.53%

-60.69%

+28.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.14%

49.95%

-27.81%

Volatility

GIB vs. OPRX - Volatility Comparison

The current volatility for CGI Inc (GIB) is 9.99%, while OptimizeRx Corporation (OPRX) has a volatility of 15.60%. This indicates that GIB experiences smaller price fluctuations and is considered to be less risky than OPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GIBOPRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.99%

15.60%

-5.61%

Volatility (6M)

Calculated over the trailing 6-month period

25.79%

54.82%

-29.03%

Volatility (1Y)

Calculated over the trailing 1-year period

29.27%

79.01%

-49.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.12%

76.06%

-52.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.68%

114.59%

-91.91%

Dividends

GIB vs. OPRX - Dividend Comparison

GIB's dividend yield for the trailing twelve months is around 0.71%, while OPRX has not paid dividends to shareholders.


PositionTTM20252024
GIB
CGI Inc
0.71%0.48%0.10%
OPRX
OptimizeRx Corporation
0.00%0.00%0.00%

Financials

GIB vs. OPRX - Financials Comparison

This section allows you to compare key financial metrics between CGI Inc and OptimizeRx Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
4.17B
19.84M
(GIB) Total Revenue
(OPRX) Total Revenue
Please note, different currencies. GIB values in CAD, OPRX values in USD

GIB vs. OPRX - Profitability Comparison

The chart below illustrates the profitability comparison between CGI Inc and OptimizeRx Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
16.4%
75.3%
Portfolio components
GIB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, CGI Inc reported a gross profit of 684.28M and revenue of 4.17B. Therefore, the gross margin over that period was 16.4%.

OPRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, OptimizeRx Corporation reported a gross profit of 14.93M and revenue of 19.84M. Therefore, the gross margin over that period was 75.3%.

GIB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, CGI Inc reported an operating income of 684.28M and revenue of 4.17B, resulting in an operating margin of 16.4%.

OPRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, OptimizeRx Corporation reported an operating income of 396.00K and revenue of 19.84M, resulting in an operating margin of 2.0%.

GIB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, CGI Inc reported a net income of 445.87M and revenue of 4.17B, resulting in a net margin of 10.7%.

OPRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, OptimizeRx Corporation reported a net income of -495.00K and revenue of 19.84M, resulting in a net margin of -2.5%.


Frequently Asked Questions


GIB and OPRX have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OPRX has higher volatility (15.60%) compared to GIB (9.99%). In terms of maximum drawdown, GIB dropped -86.78% vs OPRX's -99.32%.

OPRX currently has the higher Sharpe Ratio (-0.66 vs -1.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GIB and OPRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer